Hap Trading, LLC Incyte Corp Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$66.02 - $79.71 $3.19 Million - $3.85 Million	-48,324 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $47,568 - $55,656	-751 Reduced 1.53%	48,324 $3.55 Million
Q3 2021 Nov 10, 2021	BUY	$68.67 - $84.02 $1.49 Million - $1.82 Million	21,680 Added 79.14%	49,075 $3.38 Million
Q2 2021 Aug 11, 2021	SELL	$79.87 - $87.53 $195,122 - $213,835	-2,443 Reduced 8.19%	27,395 $2.31 Million
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $10.1 Million - $13.4 Million	-133,278 Reduced 81.71%	29,838 $2.43 Million
Q1 2018 May 11, 2018	BUY	$83.06 - $100.98 $13.5 Million - $16.5 Million	163,116 New	163,116 $13.6 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.